IIQ 4.21% 49.5¢ inoviq ltd

Ann: Trading Halt, page-35

  1. 37,911 Posts.
    lightbulb Created with Sketch. 828
    while my understanding is very limited, i personally don't see how BD1 has changed from when it was 1 cent

    the last test seemed similar to the previous test

    the difficult part is getting the technology to work with a "commercial platform"

    @mmccosk

    BARD1 is currently in discussions with a number of contract laboratory organisations that have specialty
    expertise in assay development and validation to transfer the BARD1 research essay to a commercial
    platform that will enable the BARD1 tests to be performed by most hospital and independent clinical
    laboratories around the world. “BARD1 anticipates that transfer of our research assay to a commercial
    platform will enable more efficient development and commercialisation of our diagnostic pipeline for
    detection of lung, ovarian and other cancers,” said Dr Leearne Hinch, BARD1 CEO.
    Last edited by ddzx: 21/03/18
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.